Development and Testing a Counseling strategy for drug and alcohol misuse in prisons.
- Conditions
- Health Condition 1: F10-F19- Mental and behavioral disorders due to psychoactive substance use
- Registration Number
- CTRI/2022/01/039182
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
ASSIST score in the â??moderate riskâ??. If the participant scores within the moderate-risk range for two or more of the target drugs, the intervention will be focused on the highest-scoring substance or the substance that is of most concern to the participant. Alcohol, in any case, receive the intervention. Inmates who will remain in the prison for at least 6 months following intervention; for under-trial prisoners, it will be decided on the basis of the next date of the court hearing.
Only tobacco use
Unable to provide informed consent for cognitive impairment.
Not willing to participate in the intervention and for follow-up assessments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To develop the â??enhancedâ?? component of SBIRT <br/ ><br>2. Feasibility and acceptability of brief intervention for substance use disorders in prison population <br/ ><br>3. Reduction in the ASSIST score by more or equal to 7 points in the intervention arm compared to the control arm.Timepoint: Third and Sixth months.
- Secondary Outcome Measures
Name Time Method 1. To identify the facilitators and barriers of the uptake of the intervention and to <br/ ><br>modify the intervention accordingly. <br/ ><br>2. Reduction in the frequency of illicit drug use in the intervention arm compared to <br/ ><br>the control <br/ ><br>3. Reduction in frequency of drinking days and heavy drinking days in the intervention arm compared to the control. <br/ ><br>4. Reduction of re incarceration <br/ ><br>5. Reduction of high-risk behavior. <br/ ><br>6. Reduction of overdose risk.Timepoint: 12 months